News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Videos|October 25, 2022

Cosmetic gynecology with the AUGS Publication Committee

Author(s)American Urogynecologic Society (AUGS)

Watch the latest interview in a series from members of the AUGS Publications Committee to hear from Bobby Garcia, MD, about new perspectives in cosmetic gynecology.

In this interview, Tirsit Asfaw, MD, AUGS Publications Committee liaison, interviews Bobby Garcia, MD, the writing group chair of the joint AUGS-IUGA Terminology Report on “Cosmetic Gynecology,” to provide an overview and highlight the findings of the document.

Read the full report here.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Antibiotics found to reduce wound complications after obstetric tears | Image Credit: © InfiniteFlow - © InfiniteFlow - stock.adobe.com.

Antibiotics found to reduce wound complications after obstetric tears

ByCeleste Krewson, Assistant Editor

November 4th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Future research outlook

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Positioning emerging treatments relative to established options

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: How neurokinin receptor antagonists are reshaping the VMS treatment landscape

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Special Report: Managing vasomotor symptoms in menopause | Image credit: Contemporary OB/GYN

Special Report: Recent advancements in pharmacologic and nonpharmacologic treatment options

ByJoAnn V. Pinkerton, MD,Jill Liss, MD, MSCP, FACOG

October 27th 2025

Latest CME

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis

Raj Chovatiya, MD, PhD, MSCI, FAAD; Michael Rubio, PA-C, MMSc

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances

Kathleen N. Moore, MD, MS, FASCO; Susana Banerjee, MBBS, MA, FRCP, PhD; David M. O’Malley, MD; Ritu Salani, MD, MBA

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer

Kathleen N. Moore, MD, MS, FASCO; David M. O’Malley, MD

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care

Kathleen N. Moore, MD, MS, FASCO; Ritu Salani, MD, MBA

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials

Kathleen N. Moore, MD, MS, FASCO; Prof Susana Banerjee, MBBS, MA, FRCP, PhD

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

John Brandsema, MD; Neelam Goyal, MD

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment

Rachel N. Grisham, MD; Domenica Lorusso, MD, PhD

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Community Practice Connections™: Optimizing Treatment Outcomes and Preserving Fertility in Premenopausal HR+ Breast Cancer

Rebecca Shatsky, MD; Kelly McCann, MD, PhD; Michelle L. Taylor, ANP-BC

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients With Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Jill Alldredge, MD; Emely Alfaro, MS, RN, CNS, OCN

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Show Me Your Care Plan!™ Insights for Oncology Nurses: Integrating Recent Developments to Improve Outcomes for Patients with Platinum-Resistant Ovarian Cancer

Ritu Salani, MD, MBA; Emely Alfaro, MS, RN, CNS, OCN; Jill Alldredge, MD

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Trending on Contemporary OB/GYN

FDA grants IDE approval for FemBloc non-surgical permanent birth control

Boosting cervical cancer screening in FQHCs could reach 1.8 million more women

Preterm HDP cases linked to greater CVD death in larger infants

Adverse pregnancy outcomes tied to long-term risk of atrial fibrillation

Researchers identify 4 distinct PCOS subtypes to guide treatment

© 2025 MJH Life Sciences^®

All rights reserved.